4th Quarter - Report — CRISPR THERAPEUTICS, INC. for CRISPR THERAPEUTICS, INC. (2020)

Firm

CRISPR THERAPEUTICS, INC.

Client

CRISPR THERAPEUTICS, INC.

Income

—

Expenses

$90,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Reimbursement for cell and gene therapies.

Lobbyist	Covered position, as disclosed
JOHN MARTIN	—

Contacted: Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Reimbursement for cell and gene therapies.

Lobbyist	Covered position, as disclosed
JOHN MARTIN	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Medicare/Medicaid MMM

Reimbursements for cell and gene therapies

Lobbyist	Covered position, as disclosed
JOHN MARTIN	Head of Government Affairs

Contacted: SENATE; Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.